Nicholas J. Ollberding, PhD
- Member, Division of Biostatistics and Epidemiology
- Professor, UC Department of Pediatrics
About
Biography
I’m an epidemiologist with applied research interests in pediatric cardiology, nutrition, and the impact of the developing infant intestinal microbiome on growth and early development. My areas of methodical research interest include applying and developing analytical methods for microbial metagenomic next-generation sequence data, dietary assessment and analysis methodology, predictive modeling and causal inference.
My interest in research stems from a desire to improve the health outcomes of children. I strive for the thoughtful application of epidemiologic research methods and biostatistics to support evidence-based care.
I collaborate broadly as a quantitative methodologist in health sciences research and lead the Biostatistics, Epidemiology and Research Design (BERD) Core of the Center for Clinical & Translational Science & Training (CCTST), the Microbial Metagenomics Analysis Center, and the Biostatistics Service for the Heart Institute Research Core at Cincinnati Children’s. My current work is largely focused on supporting these core services.
I have been a researcher for over 15 years and began working at Cincinnati Children’s in 2014.
PhD: Columbia University, New York, 2009.
MPhil: Columbia University, New York, 2009.
MS: University of Cincinnati, Cincinnati, OH, 2008.
BS: Miami University, Oxford, OH, 2004.
Interests
Pediatric cardiology; microbial metagenomics
Interests
Application and development of analytical methods for microbial metagenomic next-generation sequence data; dietary assessment and analysis methodology; predictive modeling; causal inference
Research Areas
Publications
Extracorporeal Membrane Oxygenation Bridge to Pediatric Lung Transplantation. Annals of the American Thoracic Society. 2025; 22:801-804.
SIGNIFICANCE OF HIGH SENSITIVITY TROPONIN-I IN DUCHENNE MUSCULAR DYSTROPHY. Journal of the American College of Cardiology. 2025; 85:1530.
EPICARDIAL ADIPOSE TISSUE IN DUCHENNE MUSCULAR DYSTROPHY CARDIOMYOPATHY. Journal of the American College of Cardiology. 2025; 85:1508.
C-C motif chemokine ligand 14 characterization for prediction of persistent severe AKI in post-cardiac surgery children. Pediatric Nephrology. 2025; 40:1103-1109.
Safety of Ablation Within the Coronary Venous Sinus in Pediatric Patients. Journal of Cardiovascular Electrophysiology. 2025; 36:848-854.
Enhanced support for adherence to rheumatic heart disease prophylaxis for children in the public health system in Uganda (CAMPS): a pragmatic randomised trial. The Lancet Global Health. 2025; 13:e707-e715.
Performance against standardization recommendations for outpatient care of common forms of congenital heart disease. Cardiology in the Young. 2025; 35:812-817.
Biomarker-based acute kidney injury sub-phenotypes refine risk assessment in children undergoing cardiac surgery. Pediatric Nephrology. 2025; 40:523-531.
Left Atrial Phasic Function via Cardiac Magnetic Resonance Imaging in Patients with Duchenne Muscular Dystrophy. Pediatric Cardiology. 2025; 46:72-80.
Characteristics and outcomes of children ≤ 10 kg receiving continuous kidney replacement therapy: a WE-ROCK study. Pediatric Nephrology. 2025; 40:253-264.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
